Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Threshold Pharmaceuticals, Inc. (NQ: THLD)
5.420 USD  -0.080 (-1.45%)
Streaming Delayed Price  /  Updated: 2:38 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Threshold Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 Next >
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
June 02, 2013
Responses Observed in Patients With Refractory Multiple Myeloma Treated With TH-302 Plus Dexamethasone; Responses Observed in Patients With Renal Cell Carcinoma and Gastrointestinal Stromal Tumors... Read More
from Marketwired News Releases
Threshold Pharmaceuticals Announces Presentations and Webcasts at Three Upcoming Investor Conferences
May 09, 2013
from Marketwired News Releases
Threshold Pharmaceuticals Reports First Quarter 2013 Financial and Operational Results
May 02, 2013
from Marketwired News Releases
Threshold Pharmaceuticals Announces Presentation and Webcast at the 12th Annual Needham Healthcare Conference
April 25, 2013
from Marketwired News Releases
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Threshold Pharmaceuticals Inc.
April 03, 2013
from PR Newswire
Threshold Pharmaceuticals Announces Presentation and Webcast at the 20th Annual Future Leaders in the Biotech Industry Conference
April 01, 2013
from Marketwired News Releases
Threshold Announces Acquisition of Investigational Hypoxia PET Imaging Agent [18F]HX4 From Siemens
March 21, 2013
Threshold to Develop PET Tracer [18F]HX4 as a Potential Companion Diagnostic for Its Hypoxia-Targeted Therapeutics Read More
from Marketwired News Releases
Programs by the FDA Designed to Speed up Approval Process for Critical Drugs a Key Factor in Biotech's Industry Success
March 12, 2013
Five Star Equities Provides Stock Research on Geron and Threshold Pharmaceuticals, Read More
from Marketwired News Releases
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2012 Financial and Operational Results
March 07, 2013
from Marketwired News Releases
Threshold Pharmaceuticals Announces Presentation and Webcast at Cowen and Company's 33rd Annual Health Care Conference
February 26, 2013
from Marketwired News Releases
Free Research Reports on THLD, SIRI, MERU and LZB Issued by the Bedford Report
February 21, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Number of FDA Drug Approvals Reach a 15-Year High in 2012
February 07, 2013
Research Driven Investing Provides Stocks Research on Nektar Therapeutics and Threshold Read More
from Marketwired News Releases
Free Research Reports on BGMD, MCP, RSH and THLD Issued by the Bedford Report
January 28, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Threshold Pharmaceuticals Announces Initiation of TH-302 Phase 3 MAESTRO Study in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
January 25, 2013
Threshold Earns a $30 Million Milestone Payment From Merck KGaA Read More
from Marketwired News Releases
Free Research Reports on DGX, MTG, SNV and THLD Issued by the Bedford Report
January 24, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
Our Pros Knew CTIC, ISIS, THLD and OCLR Would Be Top Gainers on Tuesday
January 09, 2013
from Marketwired News Releases
Free Research Reports on ARNA, CTIC, ISIS and THLD Issued by the Bedford Report
January 09, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013
January 09, 2013
Five Star Equities Provides Stock Research on ISIS Pharmaceuticals and Threshold Pharmaceuticals Read More
from Marketwired News Releases
The Real Story Behind PERI, THLD, MDCO and CGEN
January 09, 2013
from Marketwired News Releases
Threshold Pharmaceuticals Announces Presentation and Webcast at Oppenheimer 23rd Annual Healthcare Conference
December 10, 2012
from Marketwired News Releases
Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012
November 21, 2012
Five Star Equities Provides Stock Research on Ligand Pharmaceuticals and Threshold Pharmaceuticals Read More
from Marketwired News Releases
Threshold Pharmaceuticals Reports Updated Phase 2 Results Including Analyses of Maintenance Therapy With TH-302 Following Induction Therapy With TH-302 Plus Doxorubicin in Soft Tissue Sarcoma
November 15, 2012
Data Presented at the 17th CTOS Annual Meeting Read More
from Marketwired News Releases
Threshold Pharmaceuticals Announces Presentation and Webcast at Lazard Capital Markets 9th Annual Healthcare Conference
November 07, 2012
from Marketwired News Releases
Free Research Reports on COG, EXPE, GT and ZLCS Issued by the Bedford Report
November 06, 2012
The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Threshold Pharmaceuticals Reports Third Quarter 2012 Financial and Operational Results
November 02, 2012
from Marketwired News Releases
Critical Drugs Deemed to Offer Societal Benefit Could See Fast FDA Approval Process
October 26, 2012
The Paragon Report Provides Stock Research on Threshold Pharmaceuticals and Zalicus Read More
from Marketwired News Releases
Threshold Pharmaceuticals Announces Agreement With U.S. FDA on a Special Protocol Assessment for Planned Phase 3 Trial of TH-302 in Combination With Gemcitabine in Advanced Pancreatic Cancer
October 16, 2012
from Marketwired News Releases
Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures
October 10, 2012
Five Star Equities Provides Stock Research on Avanir Pharmaceuticals and Threshold Pharmaceuticals Read More
from Marketwired News Releases
Threshold Pharmaceuticals Announces Presentation and Webcast at 11th Annual BIO Investor Forum
October 04, 2012
from Marketwired News Releases
Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
September 30, 2012
from Marketwired News Releases
< Previous 1 2 3 4 5 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here